Adamas Pharmaceuticals OverviewAdamas Pharmaceuticals Net Income
Profitability analysis for ADMS.
Quarterly Net Income
-$19.52M
↓ 63.8% YoY
As of Sep 2021
Annual Net Income (TTM)
-$62.71M
↓ 0.81% YoY
Trailing 12 months ending Sep 2021
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...